GSK-FGF117360

Study Sponsor: GSK

Study Title

Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination with paclitaxel and carboplatin, or docetaxel or as Single Agent in Subjects with Solid Malignancies and Deregulated FGF Pathway Signaling

Medicine or Vaccine (generic name)

GSK3052230

Sponsor Identification Number

FGF117360

Trial Registry Identification Number(#'s)

NCT01868022 2013-000354-21

Medical Condition

Neoplasms

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=117360

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01868022

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2013-000354-21

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

June 2019